{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T07:05:44Z","timestamp":1776755144483,"version":"3.51.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National 13th Five-Year key Research & Development plan precision medical project sub project","award":["2017YFC 0908304"],"award-info":[{"award-number":["2017YFC 0908304"]}]},{"name":"the Key Medical Talents of Jiangsu Province."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s13402-021-00610-3","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T05:02:30Z","timestamp":1624597350000},"page":"907-916","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["The ATO\/miRNA-885-5p\/MTPN axis induces reversal of drug-resistance in cholangiocarcinoma"],"prefix":"10.1007","volume":"44","author":[{"given":"Yuting","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shufen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0248-2544","authenticated-orcid":false,"given":"Lin","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"key":"610_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","volume":"13","author":"JM Banales","year":"2016","unstructured":"J.M. Banales, V. Cardinale, G. Carpino, M. Marzioni, J.B. Andersen, P. Invernizzi, G.E. Lind, T. Folseraas, S.J. Forbes, L. Fouassier, A. Geier, D.F. Calvisi, J.C. Mertens, M. Trauner, A. Benedetti, L. Maroni, J. Vaquero, R.I. Macias, C. Raggi, M.J. Perugorria, E. Gaudio, K.M. Boberg, J.J. Marin, D. Alvaro, Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat. Rev. Gastroenterol. Hepatol. 13, 261\u2013280 (2016)","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"610_CR2","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","volume":"145","author":"S Rizvi","year":"2013","unstructured":"S. Rizvi, G.J. Gores, Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology\u00a0145, 1215\u20131229 (2013)","journal-title":"Gastroenterology."},{"key":"610_CR3","doi-asserted-by":"publisher","first-page":"e0183932","DOI":"10.1371\/journal.pone.0183932","volume":"12","author":"AM Lustri","year":"2017","unstructured":"A.M. Lustri, S. Di Matteo, A. Fraveto, D. Costantini, A. Cantafora, C. Napoletano, M.C. Bragazzi, F. Giuliante, A.M. De Rose, P.B. Berloco, G.L. Grazi, G. Carpino, D. Alvaro, TGF-beta signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: A study on human primary cell cultures. PLoS One 12, e0183932 (2017)","journal-title":"PLoS One"},{"key":"610_CR4","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","volume":"383","author":"N Razumilava","year":"2014","unstructured":"N. Razumilava, G.J. Gores, Cholangiocarcinoma. Lancet\u00a0383, 2168\u20132179 (2014)","journal-title":"Lancet."},{"key":"610_CR5","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s12253-009-9234-1","volume":"16","author":"F Zhong","year":"2010","unstructured":"F. Zhong, S. Zhang, C. Shao, J. Yang, X. Wu, Arsenic trioxide inhibits cholangiocarcinoma cell growth and induces apoptosis. Pathol. Oncol. Res. 16, 413\u2013420 (2010)","journal-title":"Pathol. Oncol. Res."},{"key":"610_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.biopha.2011.04.016","volume":"65","author":"D Zhao","year":"2011","unstructured":"D. Zhao, Y. Jiang, X. Dong, Z. Liu, B. Qu, Y. Zhang, N. Ma, Q. Han, Arsenic trioxide reduces drug resistance to adriamycin in leukemic K562\/A02 cells via multiple mechanisms. Biomed. Pharmacother. 65, 354\u2013358 (2011)","journal-title":"Biomed. Pharmacother."},{"key":"610_CR7","doi-asserted-by":"publisher","first-page":"7335","DOI":"10.3892\/mmr.2015.4367","volume":"12","author":"YY Zhao","year":"2015","unstructured":"Y.Y. Zhao, L. Yu, B.L. Liu, X.J. He, B.Y. Zhang, Downregulation of P-gp, Ras and p-ERK1\/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell lines. Mol. Med. Rep. 12, 7335\u20137343 (2015)","journal-title":"Mol. Med. Rep."},{"key":"610_CR8","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.3892\/ijo.2016.3700","volume":"49","author":"KA Boehme","year":"2016","unstructured":"K.A. Boehme, J. Nitsch, R. Riester, R. Handgretinger, S.B. Schleicher, T. Kluba, F. Traub, Arsenic trioxide potentiates the effectiveness of etoposide in Ewing sarcomas. Int. J. Oncol. 49, 2135\u20132146 (2016)","journal-title":"Int. J. Oncol."},{"key":"610_CR9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/s41419-018-0998-7","volume":"9","author":"J Mao","year":"2018","unstructured":"J. Mao, L. Ma, Y. Shen, K. Zhu, R. Zhang, W. Xi, Z. Ruan, C. Luo, Z. Chen, X. Xi, S. Chen, Arsenic circumvents the gefitinib resistance by binding to P62 and mediating autophagic degradation of EGFR in non-small cell lung cancer. Cell Death Dis. 9, 963 (2018)","journal-title":"Cell Death Dis."},{"key":"610_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2967\/jnumed.115.161752","volume":"57","author":"S Modak","year":"2016","unstructured":"S. Modak, P. Zanzonico, J.A. Carrasquillo, B.H. Kushner, K. Kramer, N.K. Cheung, S.M. Larson, N. Pandit-Taskar, Arsenic trioxide as a radiation sensitizer for 131I-Metaiodobenzylguanidine therapy: Results of a phase II study. J. Nucl. Med. 57, 231\u2013237 (2016)","journal-title":"J. Nucl. Med."},{"key":"610_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.etp.2007.02.001","volume":"58","author":"GX Li","year":"2007","unstructured":"G.X. Li, Q.L. Pei, Y. Gao, K.M. Liu, J.S. Nie, G. Han, Y.L. Qiu, W.P. Zhang, Protective effects of hepatocellular canalicular conjugate export pump (Mrp2) on sodium arsenite-induced hepatic dysfunction in rats. Exp. Toxicol. Pathol. 58, 447\u2013453 (2007)","journal-title":"Exp. Toxicol. Pathol."},{"key":"610_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/toxsci\/56.1.18","volume":"56","author":"Z Gregus","year":"2000","unstructured":"Z. Gregus, A. Gyurasics, I. Csanaky, Biliary and urinary excretion of inorganic arsenic: Monomethylarsonous acid as a major biliary metabolite in rats. Toxicol. Sci. 56, 8\u201325 (2000)","journal-title":"Toxicol. Sci."},{"key":"610_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbrc.2015.11.071","volume":"469","author":"S Zhang","year":"2016","unstructured":"S. Zhang, C. Ma, H. Pang, F. Zeng, L. Cheng, B. Fang, J. Ma, Y. Shi, H. Hong, J. Chen, Z. Wang, J. Xia, Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells. Biochem. Biophys. Res. Commun. 469, 55\u201361 (2016)","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Suppl 4","key":"610_CR14","doi-asserted-by":"publisher","first-page":"S687","DOI":"10.1245\/s10434-014-3812-5","volume":"21","author":"YW Chang","year":"2014","unstructured":"Y.W. Chang, M.W. Chen, C.F. Chiu, C.C. Hong, C.C. Cheng, M. Hsiao, C.A. Chen, L.H. Wei, J.L. Su, Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h\/PP2A\/NF-kappaB signaling in cervical cancer. Ann. Surg. Oncol. 21(Suppl 4), S687\u2013S695 (2014)","journal-title":"Ann. Surg. Oncol."},{"key":"610_CR15","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1111\/cas.14074","volume":"110","author":"L Tang","year":"2019","unstructured":"L. Tang, Y. Wang, H. Wang, B. Xu, H. Ji, G. Xu, X. Ge, Q. Li, L. Miao, Long noncoding-RNA component of mitochondrial RNA processing endoribonuclease is involved in the progression of cholangiocarcinoma by regulating microRNA-217. Cancer Sci. 110, 2166\u20132179 (2019)","journal-title":"Cancer Sci."},{"key":"610_CR16","doi-asserted-by":"crossref","unstructured":"F. Xu, J.J. Yan, Y. Gan, Y. Chang, H.L. Wang, X.X. He, Q. Zhao, miR-885-5p negatively regulates Warburg effect by silencing hexokinase 2 in liver cancer. Mol. Ther. Nucleic Acids\u00a018, 308\u2013319 (2019)","DOI":"10.1016\/j.omtn.2019.09.002"},{"key":"610_CR17","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2147\/OTT.S228576","volume":"13","author":"C Li","year":"2020","unstructured":"C. Li, X. Wang, Q. Song, MicroRNA 885-5p inhibits hepatocellular carcinoma metastasis by repressing AEG1. Onco. Targets Ther. 13, 981\u2013988 (2020)","journal-title":"Onco. Targets Ther."},{"key":"610_CR18","doi-asserted-by":"publisher","first-page":"16635","DOI":"10.1016\/S0021-9258(17)46269-7","volume":"265","author":"S Sen","year":"1990","unstructured":"S. Sen, G. Kundu, N. Mekhail, J. Castel, K. Misono, B. Healy, Myotrophin: Purification of a novel peptide from spontaneously hypertensive rat heart that influences myocardial growth. J. Biol. Chem. 265, 16635\u201316643 (1990)","journal-title":"J. Biol. Chem."},{"key":"610_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10238-013-0233-x","volume":"14","author":"EY Kim","year":"2014","unstructured":"E.Y. Kim, S.S. Lee, J.H. Shin, S.H. Kim, D.H. Shin, S.Y. Baek, Anticancer effect of arsenic trioxide on cholangiocarcinoma: In vitro experiments and in vivo xenograft mouse model. Clin. Exp. Med. 14, 215\u2013224 (2014)","journal-title":"Clin. Exp. Med."},{"key":"610_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12029-014-9617-8","volume":"45","author":"PR Subbarayan","year":"2014","unstructured":"P.R. Subbarayan, B. Ardalan, In the war against solid tumors arsenic trioxide needs partners. J. Gastrointest Cancer 45, 363\u2013371 (2014)","journal-title":"J. Gastrointest Cancer"},{"key":"610_CR21","doi-asserted-by":"crossref","unstructured":"J. Gao, G. Wang, J. Wu, Y. Zuo, J. Zhang, X. Jin, Skp2 expression is inhibited by arsenic trioxide through the upregulation of miRNA-330-5p in pancreatic cancer cells. Mol. Ther. Oncolytics 12, 214\u2013223 (2019)","DOI":"10.1016\/j.omto.2019.01.006"},{"key":"610_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13046-016-0407-y","volume":"35","author":"X Bao","year":"2016","unstructured":"X. Bao, T. Ren, Y. Huang, S. Wang, F. Zhang, K. Liu, B. Zheng, W. Guo, Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration\/invasion effects of arsenic trioxide on human chondrosarcoma. J. Exp. Clin. Cancer Res. 35, 129 (2016)","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"610_CR23","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.3892\/etm.2017.4226","volume":"13","author":"L Zhu","year":"2017","unstructured":"L. Zhu, F. Huang, G. Deng, W. Nie, W. Huang, H. Xu, S. Zheng, Z. Yi, T. Wan, MicroRNA-212 targets FOXA1 and suppresses the proliferation and invasion of intrahepatic cholangiocarcinoma cells. Exp. Ther. Med. 13, 2109 (2017)","journal-title":"Exp. Ther. Med."},{"key":"610_CR24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/hep.29116","volume":"66","author":"H Li","year":"2017","unstructured":"H. Li, Z.Q. Zhou, Z.R. Yang, D.N. Tong, J. Guan, B.J. Shi, J. Nie, X.T. Ding, B. Li, G.W. Zhou, Z.Y. Zhang, MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma. Hepatology\u00a066, 136\u2013151 (2017)","journal-title":"Hepatology."},{"key":"610_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s12859-019-2974-3","volume":"20","author":"E Borgmastars","year":"2019","unstructured":"E. Borgmastars, H.A. de Weerd, Z. Lubovac-Pilav, M. Sund, miRFA: an automated pipeline for microRNA functional analysis with correlation support from TCGA and TCPA expression data in pancreatic cancer. BMC Bioinf. 20, 393 (2019)","journal-title":"BMC Bioinf."},{"key":"610_CR26","first-page":"1996","volume":"17","author":"Y Liu","year":"2019","unstructured":"Y. Liu, Z. Bao, W. Tian, G. Huang, miR-885-5p suppresses osteosarcoma proliferation, migration and invasion through regulation of beta-catenin. Oncol. Lett. 17, 1996\u20132004 (2019)","journal-title":"Oncol. Lett."},{"key":"610_CR27","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/cdd.2010.164","volume":"18","author":"EA Afanasyeva","year":"2011","unstructured":"E.A. Afanasyeva, P. Mestdagh, C. Kumps, J. Vandesompele, V. Ehemann, J. Theissen, M. Fischer, M. Zapatka, B. Brors, L. Savelyeva, V. Sagulenko, F. Speleman, M. Schwab, F. Westermann, MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival. Cell Death Differ. 18, 974\u2013984 (2011)","journal-title":"Cell Death Differ."},{"key":"610_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00432-016-2248-7","volume":"143","author":"NA Hussein","year":"2017","unstructured":"N.A. Hussein, Z.A. Kholy, M.M. Anwar, M.A. Ahmad, S.M. Ahmad, Plasma miR-22-3p, miR-642b-3p and miR-885-5p as diagnostic biomarkers for pancreatic cancer. J. Cancer Res. Clin. Oncol. 143, 83\u201393 (2017)","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"610_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1042\/CS20100297","volume":"120","author":"J Gui","year":"2011","unstructured":"J. Gui, Y. Tian, X. Wen, W. Zhang, P. Zhang, J. Gao, W. Run, L. Tian, X. Jia, Y. Gao, Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin. Sci. (Lond.). 120, 183\u2013193 (2011)","journal-title":"Clin. Sci. (Lond.)."},{"key":"610_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1042\/CS20060191","volume":"112","author":"SQ Khan","year":"2007","unstructured":"S.Q. Khan, D. Kelly, P. Quinn, J.E. Davies, L.L. Ng, Myotrophin is a more powerful predictor of major adverse cardiac events following acute coronary syndrome than N-terminal pro-B-type natriuretic peptide. Clin. Sci. (Lond). 112, 251\u2013256 (2007)","journal-title":"Clin. Sci. (Lond)."},{"key":"610_CR31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0735-1097(03)00755-1","volume":"42","author":"RJ O'Brien","year":"2003","unstructured":"R.J. O'Brien, I. Loke, J.E. Davies, I.B. Squire, L.L. Ng, Myotrophin in human heart failure. J. Am. Coll. Cardiol. 42, 719\u2013725 (2003)","journal-title":"J. Am. Coll. Cardiol."},{"key":"610_CR32","doi-asserted-by":"crossref","unstructured":"A. Jafarian, M. Taghikani, S. Abroun, A. Allahverdi, M. Lamei, N. Lakpour, M. Soleimani, The generation of insulin producing cells from human mesenchymal stem cells by MiR-375 and Anti-MiR-9. PLoS One 10, e0128650 (2015)","DOI":"10.1371\/journal.pone.0128650"},{"key":"610_CR33","first-page":"254","volume":"3","author":"Y Li","year":"2010","unstructured":"Y. Li, X. Xu, Y. Liang, S. Liu, H. Xiao, F. Li, H. Cheng, Z. Fu, miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein expression. Int. J. Clin. Exp. Pathol. 3, 254\u2013264 (2010)","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"610_CR34","doi-asserted-by":"crossref","unstructured":"M.A. Muniz Lino, Y. Palacios-Rodriguez, S. Rodriguez-Cuevas, V. Bautista-Pina, L.A. Marchat, E. Ruiz-Garcia, H. Astudillo-de la Vega, A.E. Gonzalez-Santiago, A. Flores-Perez, J. Diaz-Chavez, A. Carlos-Reyes, E. Alvarez-Sanchez, C. Lopez-Camarillo, Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9. J. Proteomics\u00a0111, 198\u2013211 (2014)","DOI":"10.1016\/j.jprot.2014.04.019"},{"key":"610_CR35","doi-asserted-by":"crossref","unstructured":"B. Das, S. Gupta, A. Vasanji, Z. Xu, S. Misra, S. Sen, Nuclear co-translocation of myotrophin and p65 stimulates myocyte growth. Regulation by myotrophin hairpin loops J. Biol. Chem.\u00a0283, 27947\u201327956 (2008)","DOI":"10.1074\/jbc.M801210200"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-021-00610-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-021-00610-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-021-00610-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T10:49:04Z","timestamp":1628074144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-021-00610-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,25]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["610"],"URL":"https:\/\/doi.org\/10.1007\/s13402-021-00610-3","relation":{},"ISSN":["2211-3428","2211-3436"],"issn-type":[{"value":"2211-3428","type":"print"},{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,25]]},"assertion":[{"value":"13 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been conducted in accordance with ethical standards and according to the Declaration of Helsinki and national and international guidelines, and has been approved by the authors\u2019 institutional review board. The study protocol was approved by the Medical Ethics Committee of Nanjing Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure statement"}}]}}